Evidence map›Paper›PMID 40603363›Full record

ArticleScientific reports2025

Unraveling the NLO potential of isoquinoline functionalized chromophores via molecular modeling using DFT/TD-DFT approaches.

Iqra Shafiq, Nadeem Raza, Saba Dildar, Saifullah Bullo

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Iqra ShafiqInstitute of Chemistry, Khwaja Fareed University of Engineering & Information Technology, Rahim Yar Khan, 64200, Pakistan.
Nadeem RazaDepartment of chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Saba DildarInstitute of Chemistry, Khwaja Fareed University of Engineering & Information Technology, Rahim Yar Khan, 64200, Pakistan.
Saifullah BulloDepartment of Human and Rehabilitation Sciences, Begum Nusrat Bhutto Women University, Sukkur, Sindh, Pakistan. saifullah.bullo@bnbwu.edu.pk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The main focused of this work is the designing of isoquinoline-based derivatives through structural modeling of synthesized compound (BPDI). Two distinct series of derivatives were developed: MPBID1-MPBID6, in which electron-withdrawing groups were introduced at unfused phenyl ring on isoquinoline core and MPBID1'-MPBID6', where substitutions were made at unfused phenyl ring on isoquinoline core. Quantum chemical calculations were employed by DFT/TD-DFT at M06/6-311G(d, p) functional. Frontier molecular orbitals (FMOs), natural bonding orbital (NBO), non-linear optics (NLO), density of states (DOS), global reactivity parameters (GRPs), transition density matrix (TDM) and UV-Visible analyses of designed compounds were performed to understand their NLO responses. FMO results are supported by TDM analysis showing that all the designed compounds have smaller energy gap values than the reference compound. Among all the designed compounds, MPBID4' is the most suitable candidate for NLO study because of the lowest energy gap with a larger bathochromic redshift. NBO study has confirmed the stability of compounds. Dipole moment, average hyperpolarizability, first hyperpolarizability and second hyperpolarizability values of designed compounds were also better than that of reference compound. This study reveals that structural tailoring performs a key role in the development of attractive and best NLO materials for optoelectronic devices.

Indexed as

Global reactivity parametersMolecular designingNonlinear opticalTransition density matrix

Identifiers

PMID40603363
PMCPMC12223036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.